Day: April 21, 2026

HighlightsIndependent media feature documents 41-pound weight loss and progression to a sanctioned amateur MMA bout through TrainAlta at UFC GYM Reinforces TrainAlta’s ability to convert combat sports interest into structured, high-engagement participation Participant’s doctor reportedly said his diabetes was in remission based on pre-fight medical testingNew York, NY, April 21, 2026 (GLOBE NEWSWIRE) — – Mixed Martial Arts Group Limited (NYSE American: MMA) (“MMA” or the “Company” and doing business as MMA.INC), a technology driven ecosystem at the forefront of the global combat sports industry today highlighted a third-party participant success story that it believes provides clear, real-world validation of its TrainAlta program operating within UFC GYM locations. An April 19, 2026 feature published by L.A. TACO documented...

DURHAM, N.C., April 21, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The Company will host a conference call at 8:00 a.m. ET on that day to discuss the results. To participate in the conference call, participants should pre-register via the call registration link. All registrants will receive dial-in details and a unique PIN providing access to the live call. To avoid potential delays, participants are encouraged to join at least 10 minutes prior to the start of the call. The live webcast can be accessed at investors.fortrea.com. A replay will be available in the Events and Presentations section of the site following the conclusion...

HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that an abstract highlighting data on its lead drug candidate, annamycin, has been accepted for poster presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 – June 2, 2026, in Chicago, Illinois. The abstract, titled “Cardiac safety of L-annamycin at high cumulative anthracycline exposure: Pooled analysis,” will be presented in a poster session focused on Symptom Science and Palliative Care. Presentation Details:Session Type: Poster Session – Symptom Science and Palliative Care Presentation Date and Time: May 30, 2026, 1:30 PM – 4:30 PM CDT Location: Poster Board #8The abstract presents a pooled analysis evaluating the cardiac safety profile...

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) — BlockchAIn Digital Infrastructure, Inc. (NYSE American: AIB) (“BlockchAIn” or the “Company”), a developer and operator of digital infrastructure focused on artificial intelligence (“AI”) and high-performance computing (“HPC”) workloads, today announced today that it will hold a virtual investor webinar on Tuesday, April 28, 2026 12:00 p.m. Eastern Time. BlockchAIn Chief Executive Officer Jerry Tang, Chief Financial Officer Jolienne Halisky, and Chief Operating Officer Eyal Rozen will host the webinar to discuss the company’s recent NYSE listing, commercial progress, infrastructure strategy, and strategic collaborations. A question-and-answer session will follow. The virtual investor webinar will be accompanied by a presentation, which can be viewed during the webcast or accessed following...

The Board of Directors of Havila Shipping ASA hereby gives notice of the Ordinary General Meeting. The meeting will take place on 12 May, 2026, at 14 hours. The meeting will be held as a digital meeeting only, with no physical attendance for shareholders. The notice will be sent to shareholders, by post to the registered address in VPS, or through VPS. Contacts:Chef Executive Officer Njål Sævik, +47 909 35 722Chief Financial Officer  Arne Johan Dale, +47 909 87 706 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentHAVI_GF_innkalling_2026